在患有多囊性卵巢综合征的患者中,SIRT3 保护子宫内膜受体
Zhonghong Zeng1,2,3,4,5, Hongying Shan1,2,3,4,6, Mingmei Lin1,2,3,4
1Department of Obstetrics and Gynecology, Center for Reproductive Medicine, Peking University Third Hospital, Beijing 100191, China.
Chinese medical journal
|May 9, 2024
概括
赛尔图因3 (SIRT3) 在多囊性卵巢综合征 (PCOS) 子宫内膜中升高,通过减少氧化应激来改善细胞健康和胚胎受容性. 这表明SIRT3是PCOS相关不孕症的潜在治疗标.
科学领域:
- 生殖生物学 生殖生物学
- 内分泌学 在内分泌学.
- 细胞代谢的细胞代谢.
背景情况:
- 赛尔图因家族在细胞过程中起着至关重要的作用,但其在人类子宫内膜中的功能尚未得到充分研究.
- 多囊卵巢综合征 (PCOS) 与子宫内膜氧化失衡有关,可能会影响生育能力.
研究的目的:
- 调查sirtuin家族成员在人类子宫内膜中的表达和定位.
- 专注于sirtuin 3 (SIRT3) 和其在PCOS患者的子宫内膜氧化应激中的作用.
主要方法:
- 从PCOS患者和对照组收集的子宫内膜样本.
- 使用了细胞培养,生物能分析,siRNA,qPCR,西斑,免疫光,免疫组织化学和流细胞计.
- 研究了SIRT3在PCOS中对子宫内膜受体的保护作用和机制.
主要成果:
- 赛尔图因家族成员在子宫内膜中得到广泛的表达.
- 在PCOS患者中,SIRT3的表达显著增加,并增加了子宫内膜抗氧化剂和线粒体呼吸的减少.
- 降低SIRT3的调节损害了子宫内膜细胞的生长,增殖和胚胎受容性,这表明它在维持细胞健康方面的作用.
结论:
- 通过减轻氧化应激和调节亡,SIRT3在增强PCOS中的子宫内膜受体性方面发挥着重要作用.
- SIRT3是一种潜在的生物标志物用于预测和治疗目标,用于改善PCOS患者的子宫内膜接受度.
相关概念视频
Oogenesis
63.7K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.7K
Hormonal Regulation of the Menstrual Cycle
345
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
345
Hormonal Control of the Ovarian Cycle
475
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
475
Ovarian Cycle
1.2K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.2K


